HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regulatory T Cells Promote Apelin-Mediated Sprouting Angiogenesis in Type 2 Diabetes.

Abstract
The role of CD4+ T cells in the ischemic tissues of T2D patients remains unclear. Here, we report that T2D patients' vascular density was negatively correlated with the number of infiltrating CD4+ T cells after ischemic injury. Th1 was the predominant subset, and Th1-derived IFN-γ and TNF-α directly impaired human angiogenesis. We then blocked CD4+ T cell infiltration into the ischemic tissues of both Leprdb/db and diet-induced obese T2D mice. Genome-wide RNA sequencing shows an increased proliferative and angiogenic capability of diabetic ECs in ischemic tissues. Moreover, wire myography shows enhanced EC function and laser Doppler imaging reveals improved post-ischemic blood reperfusion. Mechanistically, functional revascularization after CD4 coreceptor blockade was mediated by Tregs. Genetic lineage tracing via Cdh5-CreER and Apln-CreER and coculture assays further illustrate that Tregs increased vascular density and induced de novo sprouting angiogenesis in a paracrine manner. Taken together, our results reveal that Th1 impaired while Tregs promoted functional post-ischemic revascularization in obesity and diabetes.
AuthorsOscar M Leung, Jiatao Li, Xisheng Li, Vicken W Chan, Kevin Y Yang, Manching Ku, Lu Ji, Hao Sun, Herman Waldmann, Xiao Yu Tian, Yu Huang, James Lau, Bin Zhou, Kathy O Lui
JournalCell reports (Cell Rep) Vol. 24 Issue 6 Pg. 1610-1626 (08 07 2018) ISSN: 2211-1247 [Electronic] United States
PMID30089270 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.
Chemical References
  • Apelin
Topics
  • Animals
  • Apelin (metabolism)
  • Diabetes Mellitus, Type 2 (genetics, metabolism)
  • Humans
  • Mice
  • Neovascularization, Pathologic
  • T-Lymphocytes, Regulatory (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: